Oridonin Ameliorates Nonalcoholic Steatohepatitis by Regulating Pyroptosis through the NF-κB/NLRP3 AxisOA
Background:Nonalcoholic steatohepatitis(NASH)is a liver disease characterized by inflammation and fibrosis.Oridonin(Ori)exhibits anti-inflammatory and anti-fibrotic properties,but its role in NASH remains unclear.The study aimed to investigate whether Ori alleviates NASH injury by regulating pyroptosis through the nuclear factor-κB(NF-κB)/nucleotide-binding oligomerization domain-like receptor protein 3(NLRP3)axis.Methods:An in vitro NASH model was established in HepG2 cells using free fatty acids(FFA),and an in vivo model was induced in mice using a methionine-choline-deficient(MCD)diet.Biochemical assays,staining,flow cytometry,Western blot,and immunofluorescence assessed lipid accumulation,oxidative stress,inflammation,pyroptosis,and fibrosis.Results:Ori treatment(2.5-10μM)dose-dependently reduced FFA-induced cell injury,lipid accumulation,reactive oxygen species(ROS)production,and release of interleukin(IL)-1β and IL-18,while decreasing PI and Caspase-1-positive cells and expression of N-GSDMD(p<0.05).Ori also suppressed the expression of fibrosis markers alpha smooth muscle actin(α-SMA),Collagen Ⅲ,and fibronectin(p<0.05).InMCD-fed mice,Ori significantly attenuated hepatic steatosis,oxidative stress,inflammation,pyroptosis,and fibrosis,and alleviated liver enzyme levels and stiffness(p<0.05).Mechanistically,Ori inhibited NF-κB activation(p-p65 and p-IκBα)and NLRP3 inflammasome assembly,as confirmed by lipopolysaccharide(LPS)/adenosine triphosphate(ATP)experiments.Conclusion:Ori can delay NASH progression via suppressing the NF-κB/NLRP3 pathway,reducing liver cell damage,lipid deposition,inflammation,pyroptosis,and fibrosis.
Qianqian Peng;Fengjian He;Shumin Pan;Yinghua Ou
Department of Gastroenterology,The Third Affiliated Hospital of Southern Medical University,Guangzhou,ChinaDepartment of Gastroenterology,The Third Affiliated Hospital of Southern Medical University,Guangzhou,ChinaDepartment of Gastroenterology,The Third Affiliated Hospital of Southern Medical University,Guangzhou,ChinaDepartment of Gastroenterology,The Third Affiliated Hospital of Southern Medical University,Guangzhou,China
医药卫生
Nonalcoholic steatohepatitisoridoninpyroptosislipid accumulationnuclear factor-κB(NF-κB)/nucleotide-binding oligomerization domain-like receptor protein 3(NLRP3)pathway
《BIOCELL》 2026 (9)
P.215-242,28
评论